Skip to contentB
Bausch Health Companies Inc.
B
BHCBausch Health Companies Inc. Source filing unavailable
Q1 2013 · —
Revenue$1.07B$1.07B+24.8% vs Q1 2012 Net Income-$27.50M-$27.50MN/M vs Q1 2012 EPS Diluted-$0.09-$0.09N/M vs Q1 2012 Operating Income$117,000,000+90.3% Operating Cash Flow$255,300,000+52.7% Free Cash Flowderived
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bausch Health Companies Inc. · CIK 885590 · Engraved from SEC EDGAR
$241,300,000
+54.6%
Margins · derivedOperating margin11.0%+3.8 pt vs Q1 2012
Net margin-2.6%−23.4 pt vs Q1 2012